Both in Biotechnology
Replimune Group vs Vericel
Over the past year REPL returned +121.9% and VCEL returned +11.9%; their daily moves had a correlation of -0.03.
REPL +121.9% VCEL +11.9%Growth of $1, one year, split-adjusted
| Metric | REPL | VCEL |
|---|---|---|
| Price | $20.65 | $41.09 |
| Market cap | $1.96B | $2.10B |
| Today | +5.95% | +1.43% |
| 1 month | +57.0% | 0.0% |
| 6 months | +619.5% | +11.6% |
| Year to date | +112.4% | +14.1% |
| 1 year | — | +17.2% |
| Revenue growth (YoY) | — | +22.5% |
| Gross margin | — | 72.8% |
| Net margin | — | 2.8% |
| P/E (TTM) | — | 86.9× |
| Price / sales | — | 6.9× |
| Net cash | $183.7M | $162.5M |
| Dividend yield | — | — |
| Volatility (60d) | 77.7% | 32.8% |
| Short % of float | 29.6% | 11.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).